Three weeks after Sophia Bassan’s mastectomy, she felt a stabbing pain beneath her right armpit. In the following months, painful shocks radiated through her chest and back. Her body became so sensitive that at times she couldn’t wear a shirt or lift a fork to her mouth. Bassan slept sitting up because it hurt to…
OAKLAND, Calif. — Rosa María Carranza leaned forward to hold a 3-year-old’s back as the girl climbed a rock in the forested hills of northeast Oakland. Dressed in hiking gear and beaded necklaces, Carranza, 67, maneuvered between trees and children on a sunny morning in December. “Hold on to that branch,” she said in Spanish….
Tom Kelly is the CEO of Heidi Health, another of the many ambient AI scribes that is spreading its wings to other roles, including bringing its own AI Open Evidence competitor! He calls it an AI care partner. Heidi started in Australia, and quickly moved to the UK and Canada, but now are in over…
Startup Pinnacle Medicines is developing peptide drugs with the same efficacy as biologic medicines and the dosing convenience of oral small molecules. The lead program of OrbiMed-incubated Pinnacle is on track to enter the clinic in asthma and chronic obstructive pulmonary disease. The post Pinnacle Medicines Adds $89M for Oral Peptides With Properties of Injectable…
Uma Veerappan of Flare Capital Partners thinks the healthcare AI startups that will come out on top will be companies that integrate seamlessly into workflows, build proprietary datasets and quickly determine how to sell their technology. The post What Will Separate Healthcare AI Winners From Losers? appeared first on MedCity News.
Over the past 15 years, financial and administrative barriers – most notably step therapy mandates and prior authorization requirements – have repeatedly forced patients through suboptimal or ineffective treatments before they can try another therapy, have tied the hands of healthcare professionals and patients alike. Now there’s a possible solution. The post Join the Fight…
A PwC report finds that women’s health is evolving into a much larger, high-growth market as investment expands beyond reproductive care, though it remains underfunded and under-researched. The post The Women’s Health Market Is Poised to Reach $600B by 2030. That’s if ‘We Do Nothing’ appeared first on MedCity News.
An algorithm can flag an irregular heartbeat. But it cannot notice that Tom hasn’t mentioned his late wife in two weeks, or that he’s wearing the same shirt for the fourth day running. Those observations require a person in the room, not a sensor on the wall. The post The Algorithm Won’t Hold Your Mother’s…
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed a new weight loss pill approved by the FDA on CBS News’ CBS Mornings on April 2. Click here to watch Gounder on CBS Mornings. KFF Health News Southern correspondent Sam Whitehead discussed high Affordable Care Act premiums on WUGA’s The Georgia Health Report on…
Generic medicines face no tariffs, though the Trump administration reserves the right to revisit that in the future. Some branded drugmakers face a reduced tariff rate, but that could change if they don’t reach a so-called most-favored nation drug price deal. The post The Drug Companies Avoiding Trump’s Tariffs — For Now appeared first on…
